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Abstract 14 
 15 
The Australian sheep blowfly, Lucilia cuprina, is a primary cause of sheep flystrike and a 16 
major agricultural pest. Cytochrome P450 enzymes have been implicated in the resistance of 17 
L. cuprina to several classes of insecticides. In particular, CYP6G3 is a L. cuprina homologue 18 
of Drosophila melanogaster CYP6G1, a P450 known to confer multi-pesticide resistance. To 19 
investigate the basis of resistance, a bicistronic Escherichia coli expression system was 20 
developed to co-express active L. cuprina CYP6G3 and house fly (Musca domestica) P450 21 
reductase. Recombinant CYP6G3 showed activity towards the high-throughput screening 22 
substrates, 7-ethoxycoumarin and p-nitroanisole, but not towards p-nitrophenol, coumarin, 7-23 
benzyloxyresorufin, or seven different luciferin derivatives (P450-Glo™ substrates). The 24 
addition of house fly cytochrome b5 enhanced the kcat for p-nitroanisole dealkylation 25 
approximately two fold (17.8 ± 0.5 vs 9.6 ± 0.2 min-1) with little effect on KM (13 ± 1 vs 10 ± 26 
1 µM). Inhibition studies and difference spectroscopy revealed that the organochlorine 27 
compounds, DDT and endosulfan, and the organophosphate pesticides, malathion and 28 
chlorfenvinphos, bind to the active site of CYP6G3. All four pesticides showed type I binding 29 
spectra with spectral dissociation constants in the micromolar range suggesting that they may 30 
be substrates of CYP6G3. While no significant inhibition was seen with the organophosphate, 31 
diazinon, or the neonicotinoid, imidacloprid, diazinon showed weak binding in spectral 32 
assays, with a Kd value of 23 +/- 3 µM.  CYP6G3 metabolised diazinon to the diazoxon and 33 
hydroxydiazinon metabolites and imidacloprid to the 5-hydroxy and olefin metabolites, 34 
consistent with a proposed role of CYP6G enzymes in metabolism of phosphorothioate and 35 
neonicotinoid insecticides in other species. 36 
 37 
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 40 
Abbreviations: 7EC – 7-ethoxycoumarin; BR- 7-benzyloxyresorufin; CuOOH – cumene 41 
hydroperoxide; δ-ALA – delta-aminolevulinic acid; DDT – dichlorodiphenyltrichloroethane 42 
DTT – dithiothreitol; EDTA - ethylenediaminetetraacetic acid; fCPR – cytochrome P450 43 
reductase from Musca domestica; fb5 – cytochrome b5 from Musca domestica; IPTG - 44 
isopropyl β-D-1-thiogalactopyranoside; IMP - 2-isopropyl-6-methyl-4-pyrimidinol; LC-45 
MS/MS – liquid chromatography mass spectrometry/mass spectrometry; luciferin-BE - 46 
luciferin 6’-benzyl ether; luciferin-CEE - luciferin 6’-chloroethyl ether; luciferin-H - 6’-47 
deoxyluciferin; luciferin-H-EGE - 6’-deoxyluciferin 4-ethylene glycol ester; luciferin-ME - 48 
luciferin 6’-methyl ether; luciferin-ME-EGE - luciferin 6’-methyl ether 4-ethylene glycol 49 
ester; luciferin-PFBE - luciferin 6’-pentafluorobenzyl ether; P450 – cytochrome P450; PMSF 50 
- phenylmethylsulfonyl fluoride; pNAOD – p-nitroanisole O-dealkylation; pNP – p-51 
nitrophenol; pNA – p-nitroanisole. 52 
53 
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1.  Introduction 54 
 55 
Cutaneous myiasis, known also as flystrike, is a lethal ectoparasitic infection of sheep. 56 
Flystrike is most prevalent in Australia—owing to climate, farming conditions and susceptible 57 
breeds—and costs graziers upwards of AUD150 million annually (Capinera, 2008; Levot, 58 
2012; Phillips, 2009). Lucilia cuprina, the Australian sheep blowfly, causes 90% of these 59 
flystrike infections (Levot, 1995b, a; Phillips, 2009). Instances of flystrike are seen globally, 60 
with warmer tropical regions, such as New Zealand and South Africa, being affected by L. 61 
cuprina-mediated myiasis more frequently than colder regions, including parts of northern 62 
Europe, where flystrike is mostly caused by Lucilia sericata (Wall, 2012).  63 
Traditionally, the process of mulesing, which involves surgically removing skin folds 64 
from areas of the sheep where the flies most commonly oviposit, is used as an effective 65 
method to prevent strike infections. However, mulesing has raised ethical concerns and is 66 
now illegal in many countries (Phillips, 2009). Chemical methods of flystrike treatment have 67 
since been applied, with organochlorine, organophosphorus, and triazine pesticides all having 68 
been used (Joshua and Turnbull, 2015). However, resistance has arisen in L. cuprina to to 69 
organochlorine, organophosphorus, benzoylurea, pyrethroid, and carbamate pesticides 70 
(Hughes, 1982; Hughes and Devonshire, 1982; Kotze, 1993; Kotze, 1995; Kotze and Sales, 71 
1994), further complicating the management of flystrike in the grazing industry (Heath and 72 
Levot, 2015; Levot, 1995b, a; Phillips, 2009).  73 
Cytochrome P450 enzymes are a ubiquitous class of hemoproteins present in all 74 
classes of life. These enzymes catalyse over 60 types of reactions and are responsible for a 75 
diverse array of biosynthetic and degradative processes in vivo, including xenobiotic 76 
detoxification (Guengerich, 2001). Many P450 enzymes have been linked to insecticide 77 
resistance (Feyereisen, 2012; Gillam and Hunter, 2007; Heckel, 2010; Li et al., 2007b). It is 78 
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generally presumed and sometimes proven that they confer resistance by detoxifying 79 
pesticides and accelerating their clearance from the insect. However, P450s may be associated 80 
with the metabolic bioactivation of certain pesticides to toxic, active metabolites. An example 81 
is the conversion of the phosphorothioate, diazinon, to its active metabolite, diazoxon 82 
(Feyereisen, 2012). P450s have been proposed to both bioactivate diazinon to diazoxon and 83 
its hydroxyl metabolite and to detoxify it to hydroxydiazinon and 2-isopropyl-6-methyl-4-84 
pyrimidinol (IMP) (Ellison et al., 2012; PisaniBorg et al., 1996; Shishido et al., 1972; Wilson 85 
et al., 1999). An esterase is known to detoxify diazoxon in L. cuprina (Hartley et al., 2006; 86 
Newcomb et al., 1997) but the enzymes responsible for the metabolism of diazinon to 87 
diazoxon or hydroxydiazinon are yet to be identified. 88 
Pesticide resistance in the model fly species Drosophila melanogaster has been 89 
extensively characterized (Feyereisen, 2012). In Drosophila, CYP6G1 has been associated 90 
with resistance to many other classes of insecticides (Cheesman et al., 2013; Daborn et al., 91 
2007; Feyereisen, 2012) including the neonicotinoid, imidacloprid (Fusetto et al., 2017; Hoi et 92 
al., 2014). The proposed CYP6G1 ortholog in houseflies, CYP6G4 has similarly been 93 
associated with resistance to multiple pesticides, including imidacloprid and spinosad (Gao et 94 
al., 2012; Hojland et al., 2014). 95 
P450s have been implicated in L. cuprina resistance for decades (Hughes, 1982; 96 
Hughes and Devonshire, 1982; Kotze and Sales, 1994; Kotze et al., 1997) but no biochemical 97 
studies of specific L. cuprina P450 enzymes have been done to date. Since CYP6G3 from L. 98 
cuprina is in the same subfamily as CYP6G1 and CYP6G4 we hypothesized that it may also 99 
play a role in insecticide metabolism. The objective of this work was to develop a bacterial 100 
expression system to generate active CYP6G3 and to characterise the interaction of this 101 
enzyme with several classes of insecticides with the aim of gaining a better understanding of 102 
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the xenobiotic detoxification capacities of L. cuprina. In particular, we sought to determine 103 
the role of CYP6G3 in the metabolism of diazinon and imidacloprid. 104 
 105 
2.  Materials and Methods 106 
 107 
2.1.  Materials 108 
 109 
 Isopropyl β-D-1-thiogalactopyranoside (IPTG), δ-aminolevulinic acid (δ-ALA ), DTT, 110 
bestatin, aprotinin, leupeptin, pepstatin, and phenylmethylsulfonyl fluoride (PMSF) were 111 
obtained from Sigma Chemical Co (St. Louis, MO). T4 DNA ligase, was from Promega 112 
(Madison, WI), and DH5α F′IQ™ Max Efficiency cells were purchased from Invitrogen 113 
(Carlsbad, CA). Pwo DNA polymerase was from Roche Applied Science (Indianapolis, IN), 114 
and QIAquick PCR Purification and Gel Extraction Kits were from Qiagen (Valencia, CA). 115 
P450-glo reagents were from Promega (Madison, WI). The pesticides chlorfenvinphos, 116 
endosulfan and dicyclanil were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, 117 
CA), diazinon was obtained from Chem Service (West Chester, PA), and malathion, 118 
lufenuron, carbaryl, and DDT were obtained from Sigma-Aldrich (St. Louis, MO). 119 
Imidacloprid (N-[1-[(6-Chloro-3-pyridyl)methyl]-4,5-dihydroimidazol-2-yl]nitramide) was 120 
obtained from AnalaR (supplied by BDH, Poole, Great Britain). 13C6-imidacloprid was 121 
provided by IsoSciences (PA, USA). 5-hydroxy-imidacloprid and olefin-imidacloprid were 122 
purchased from Bayer AG (Leverkusen, North Rhine-Westphalia, Germany). HPLC grade 123 
acetonitrile and HPLC grade methanol were obtained from Merck (Kenilworth, NJ, U.S.A.). 124 
Glacial formic acid was provided by AnalaR (supplied by BDH, Poole, Great Britain). 18.2 125 
MΩ HPLC grade water was obtained from Honeywell (Morristown, NJ, USA). Other 126 
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chemicals and reagents were of the highest quality commercially available from local 127 
suppliers and were used as purchased.  128 
The pCW6G1-Barnes/fCPR vector was from another study (Cheesman et al., 2013). The 129 
expression vectors for house fly cytochrome b5 and CPR, pCb5 (Guzov et al., 1996) and pI-95 130 
(Andersen et al., 1994), were generous gifts of Professor R. Feyereisen, while the chaperone 131 
plasmid set was obtained as a generous gift from Professor K. Nishihara (HSP Research 132 
Institute, Kyoto Japan) (Nishihara et al., 1998). 133 
 134 
2.2. Construction of the pCW6G3-Barnes/fCPR expression plasmid 135 
 136 
The cDNA for CYP6G3 (Genbank accession number: DQ917668) was obtained from a 137 
cDNA library as described previously (Lee et al., 2011) and cloned into the pUAS-attB 138 
vector. A bacterial expression plasmid containing the cDNAs for CYP6G3 and housefly 139 
cytochrome P450 reductase (fCPR) arranged in a bicistronic format was constructed using the 140 
pCW6G1-Barnes/fCPR vector (Cheesman et al., 2013) from which the 6G1 cDNA had been 141 
removed with an NdeI and SalI digestion. The Cyp6g3 gene was amplified from the source 142 
plasmid, pUAS-attb-Lc6G3, with a forward primer (5’- 143 
GGAGGTGGACATATGGCTCTGTTATTAGCAGTTTTTTTCATTACCTGTATTCTTGG-144 
3’) that incorporated an NdeI restriction site into the start codon and encoded the 145 
MALLLAVFL N-terminal sequence to facilitate expression (Barnes et al., 1991). The reverse 146 
primer (5’- 147 
GTGGTGGTGGTCGACTTAACAAGTATATTTTTATCATAGAGATTATCTCTTATCAC148 
-3’) added a SalI restriction site to the end of the open reading frame to enable subcloning into 149 
the NdeI and SalI sites of the pCW6G1-Barnes/fCPR vector in place of the CYP6G1 150 
sequence. In this manner, the CYP6G3 sequence was also modified to contain a C-terminal 151 
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hexa-histidine affinity tag connected with a serine/threonine linker to facilitate future 152 
purification.  153 
 154 
2.3.  Expression in E. coli and preparation of bacterial membranes 155 
 156 
 The pCW6G3-Barnes/fCPR plasmid was co-expressed in DH5αF’IQTM E. coli cells 157 
containing the chaperone expression plasmid pGro7 (Nishihara et al., 1998) using a standard 158 
expression protocol (Notley et al., 2002). A single colony was inoculated into 5 ml LB media 159 
with 100 µg/ml ampicillin and 20 µg/ml chloramphenicol and grown overnight with shaking 160 
at 37°C. Expression cultures of 100 ml terrific broth containing 1 mM thiamine, 100 µg/ml 161 
ampicillin, 20 µg/ml chloramphenicol, and trace elements (Bauer and Shiloach, 1974) were 162 
inoculated with 1 ml of starter culture. Expression cultures were incubated at 25°C with 163 
shaking for 5 h before induction with the addition of 4 mg/ml arabinose, 1 mM IPTG, and 0.5 164 
mM δ-ALA. Expression cultures were incubated with shaking at 25°C for a further 43 h (48 h 165 
total) before harvest. Bacterial membranes containing recombinant CYP6G3 and fCPR were 166 
prepared via ultracentrifugation following lysis in a French Press as described previously 167 
(Cheesman et al., 2013) and stored at -80°C prior to use. 168 
 To supplement enzymatic reactions with controlled and reproducible amounts of P450 169 
reductase, membranes containing fCPR were generated from bacteria expressing recombinant 170 
fCPR alone from the pCW/fCPR vector (Cheesman et al., 2013) in the same manner as 171 
described above. Additionally, membranes containing housefly cytochrome b5 (fb5) were 172 
generated similarly from cultures expressing the pCb5 vector (Cheesman et al., 2013; Guzov 173 
et al., 1996). 174 
 The concentration of CYP6G3 was measured in membrane preparations via Fe (II).CO 175 
vs Fe(II) difference spectroscopy (Omura and Sato, 1964). Microsomal fCPR content was 176 
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measured using cyt c as a surrogate electron acceptor and assuming a specific activity of 3024 177 
nmol cyt c reduced min-1 nmol fCPR-1(Murataliev et al., 1999). Microsomal fb5 content was 178 
measured via difference spectroscopy as described by Estabrook and Werringloer (Estabrook 179 
and Werringloer, 1978) with an OLIS-modified Aminco DW2a spectrophotometer. 180 
 181 
2.4.  Characterization of activity toward marker substrates 182 
 183 
 Thirteen potential marker substrates were screened for CYP6G3 activity. The 184 
fluorogenic substrates coumarin (Waxman and Chang, 2006a), 7-ethoxycoumarin (7EC) 185 
(Waxman and Chang, 2006b) and 7-benzyloxyresorufin (Stresser et al., 2002); the 186 
colorimetric substrates p-nitrophenol (pNP) (Chang et al., 2006) and p-nitroanisole (pNA) 187 
(Hansen and Hodgson, 1971); and the luminogenic P450-glo substrates (Cali et al., 2006), 188 
luciferin-ME, -CEE, -H, –BE, -PFBE, -ME-EGE and –H-EGE were assayed as described 189 
previously (Cheesman et al., 2013). All reactions included 50 nM CYP6G3 and were initiated 190 
by the addition of either 500 µM cumene hydroperoxide (CuOOH) for the fluorogenic 191 
substrates, or an NADPH-regenerating system (10 mM glucose-6-phosphate, 250 µM 192 
NADP+, and 0.5 U/ml glucose-6-phosphate dehydrogenase) for the colorimetric and 193 
luminogenic substrates. CuOOH was used as the electron source in the fluorescence assays 194 
rather than NADPH so that the generation of the dealkylated products could be monitored via 195 
fluorescence intensity measurements in real time without interference from NADPH 196 
fluorescence. The electron transfer proteins fCPR and fb5 were supplemented where indicated 197 
to a final level of 250 nM and 500 nM, respectively, in reactions supported by the NADPH-198 
regenerating system.  199 
 Catalytic constants were measured for p-nitroanisole O-dealkylation (pNAOD) in the 200 
presence and absence of 500 nM fb5 as described previously (Cheesman et al., 2013). 201 
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Catalytic constants were measured for 7-ethoxycoumarin O-dealkylation (7ECOD) supported 202 
by CuOOH in the absence of fb5 or additional fCPR above the level already present in the 203 
bicistronic membranes. The inhibition of 7ECOD at 1 mM 7EC was measured similarly 204 
without additional fCPR or fb5 in the presence of 100, 10, 1, 0.1, 0.01 and 0 µM inhibitor. 205 
GraphPad prism was used to calculate IC50 values using the following equation, 206 
Y=100/(1+10^((LogIC50-X)*HillSlope)).  207 
 208 
2.5.  Ligand binding experiments 209 
 210 
Ligand-induced difference spectra were recorded in an OLIS-modified Aminco DW2a 211 
spectrophotometer as previously described (Jefcoate, 1978). CYP6G3-containing membranes 212 
from cells transformed with the bicistronic vector were diluted to 0.46 µM in TES buffer (50 213 
mM Tris acetate, 250 mM sucrose, 0.25 mM EDTA, pH 7.6) and the membrane suspension 214 
was split between sample and reference cuvettes. Ligands were dissolved in methanol and 215 
sequential, equal additions of dissolved ligand and methanol were added to the sample and 216 
reference cuvettes respectively, to produce the ligand concentrations indicated in individual 217 
figures. The total, final concentration of methanol was kept below 2 %.  218 
 219 
2.6.  Characterization of imidacloprid metabolism  220 
CYP6G3-mediated imidacloprid metabolism was assessed in vitro by incubating 221 
bacterial membranes with 12C6 and 13C6- imidacloprid in a 50:50 ratio to allow the 222 
identification of imidacloprid metabolites through the use of the twin-ion method described 223 
previously (Hoi et al., 2014). The two isotopes of imidacloprid were dissolved in HPLC grade 224 
water in separate volumetric flasks and the isotopes united only at the start of the experiment. 225 
Bacterial membranes containing CYP6G3 (0.10 µM) and fCPR (0.18 µM) were incubated 226 
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with 25 µM or 500 µM imidacloprid (total concentration) in 100 mM potassium phosphate 227 
buffer, pH 7.4. Reactions were initiated by the addition of an NADPH-regenerating system 228 
(10 mM glucose-6-phosphate, 250 µM NADP+, and 0.5 U/ml glucose-6-phosphate 229 
dehydrogenase) as described above. Negative controls lacked either Cyp6g3 (CPR only) or 230 
the NADPH-generating system components (-NGS) or were terminated immediately after 231 
addition of the NADPH-generating system (T = 0). A substrate only control was also used 232 
which comprised substrate added to a buffer solution (Substrate only) to monitor any 233 
chemical degradation of imidacloprid. After 2 hours at 37°C, the reactions were stopped 234 
adding 500 µL of cold methanol and transferring the tubes to ice for an hour to facilitate 235 
precipitation of proteins. The samples were clarified by centrifuging the tubes for 6 minutes at 236 
16 000 x g and the supernatants were recovered. A second extraction was performed with 500 237 
µL of cold methanol and the combined extracts were evaporated under vacuum. The dried 238 
residues were stored in the freezer (-20°C) prior to analysis of the metabolites.  239 
Imidacloprid metabolites were analysed as described previously by Fusetto et al., (2017). 240 
Briefly, the dried extracts were resuspended in HPLC grade water, and analysed using an 241 
Agilent 1100 HPLC autosampler system with a reverse-phase C18 column (2.6 µm, 3.0 × 100 242 
mm, Kinetex XB-C18, Phenomenex, Inc., Torrance, California, USA) coupled to an Agilent 243 
6520 Q-TOF mass spectrometer (Agilent Technologies, Inc., Santa Clara, CA, USA). 244 
Separation was achieved using a two solvent gradient consisting of 100% water (Phase 1) and 245 
a 70:30:0.1% mixture of acetonitrile, H2O, and formic acid, respectively (Phase 2). 246 
Imidacloprid, and its 5-hydroxyimidacloprid (5OH) and imidacloprid olefin (Olefin) 247 
metabolites were analysed in both positive and negative mode and quantified using calibration 248 
curves (R2=0.989, R2=0.999 and R2=0.999 respectively) generated by multiple injections of 249 
the pure standard at different concentrations. 250 
 251 
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2.7.  Characterization of diazinon metabolism  252 
Incubations were undertaken as described above with 100 µM diazinon, 0.5 µM 253 
CYP6G3 and 0.75 µM fCPR. Reactions were stopped after 2 h with two volumes of 254 
acetonitrile.  Diazinon metabolism was analysed as described in detail previously (Ellison et 255 
al., 2012) except that an Agilent Zorbax 5µm 4.6 mm x 150 mm SB-C18 column was used.   256 
LC-MS analysis was performed using a Bruker micrOTOF-Q mass spectrometer operated in 257 
positive ion mode.  Source parameters included a capillary voltage of 4500 V; drying gas 258 
temperature at 250° C; drying gas flow at 6 L/min; nebuliser pressure 4 bar and collision 259 
energy of 16 eV.  Data was acquired in a data dependent manner with MS2 analyses being 260 
performed on the three most intense ions.  Chromatographic separation was performed using a 261 
Dionex Ultimate 3000 HPLC system equipped with a Zorbax Eclipse XDB-C-18 column (2.1 262 
x 50 mm, 3.5 µm) at 300 µL per minute.  Solvent A was 2% acetonitrile and solvent B was 263 
90% acetonitrile.  The separation gradient was 0-11 minutes 2% B; 11-14 minutes 45% B; 14-264 
16 minutes 95% B.  Compound identification was confirmed by matching MS2 fragmentation 265 
data against the MassBank database (http://www.massbank.jp) and data previously published 266 
(Kouloumbos et al., 2003). 267 
 268 
 269 
3.  Results 270 
 271 
3.1.  CYP6G3 expression, membrane preparation, and protein quantitation 272 
 273 
 The bicistronic expression vector pCW6G3-Barnes/fCPR was generated with the 274 
cDNA for Cyp6g3 and housefly cytochrome P450 reductase (fCPR). The Cyp6g3 gene was 275 
modified with the N-terminal MALLLAVFL sequence (Barnes et al., 1991) to facilitate 276 
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expression in E. coli. Expression yields from the pCW6G3-Barnes/fCPR vector were 277 
approximately 200 nmol P450 holoprotein per L culture, which yielded membrane 278 
preparations containing 2.3 µM CYP6G3 holoprotein and 3.2 µM fCPR. A reduced CO-279 
bound difference spectrum of CYP6G3-containing membranes is shown in Figure 1. The 280 
Soret maximum is at 450 nm. The shoulder at 417-420 nm may indicate either some 281 
conversion of P450 holoprotein to the inactive P420 form or the presence of bacterial 282 
cytochromes (Kita et al., 1984).  283 
 284 
3.2.  Metabolism of marker substrates by CYP6G3 285 
 286 
 Thirteen marker substrates were tested for CYP6G3 activity. CYP6G3 showed activity 287 
towards the fluorogenic substrate 7-ethoxycoumarin and the colorimetric substrate p-288 
nitroanisole, but no significant activity was seen towards p-nitrophenol, coumarin, 7-289 
benzyloxyresorufin, or with several luminogenic P450-Glo substrates: luciferin-Me, -CEE, -290 
H, –BE, -PFBE, -ME-EGE or –H-EGE. 291 
 The rates of CYP6G3-mediated pNAOD and 7ECOD activity were fit well by the 292 
Michaelis-Menten equation over the concentration ranges shown in Figure 2. Kinetic 293 
constants are shown in Table 1. CYP6G3 pNAOD activity was stimulated by fb5 with a nearly 294 
two-fold increase in kcat and essentially no change in KM (Figure 2).  295 
 296 
3.3.  Screening for inhibition of 7ECOD 297 
 298 
 CYP6G3-mediated 7ECOD activity was used to screen a selection of ligands for 299 
interaction with the CYP6G3 active site, including pesticides, and ketoconazole, a P450 300 
inhibitor (Figure 3). Ligands were tested for inhibition of 7ECOD at 1 mM 7EC (the 301 
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measured KM). Chlorfenvinphos, malathion, DDT, endosulfan, and ketoconazole all showed 302 
significant inhibition of 7ECOD with calculated IC50 values ranging from 0.23 µM to 26.8 303 
µM  (Table 2), while imidacloprid, dicyclanil, lauric acid, diazinon and biphenyl showed 304 
negligible inhibition at concentrations up to 100 µM. Lufenuron and carbaryl showed slight 305 
inhibition (data not shown), but the IC50 value exceeded the highest assayed concentration and 306 
could not be estimated accurately. 307 
 308 
3.4.  Ligand-binding difference spectra 309 
 310 
Ligand-binding difference spectra were obtained as an additional method to probe the 311 
interaction of ligands with the CYP6G3 active site. Chlorfenvinphos, malathion, DDT, 312 
endosulfan, and diazinon exhibited type I binding spectra with absorbance maxima near 390 313 
nm and minima near 420 nm (Figure 4). Ketoconazole binding exhibited a type II spectrum 314 
with a spectral dissociation constant (KS) of 4.3 ± 0.3 µM (Table 2). Endosulfan induced the 315 
difference spectrum with the largest absolute amplitude (∆Amax), while chlorfenvinphos 316 
bound with the largest spectral binding intensity (∆Amax/KS)(Shimada et al., 2013; Shimada et 317 
al., 2009). A weak type I binding spectrum was elicited by imidacloprid, but the Ks value 318 
could not be determined accurately (data not shown). 319 
 320 
3.5.  Metabolism of pesticide substrates by CYP6G3 321 
Imidacloprid was metabolized to the 5-hydroxy and olefin metabolites at both 25 and 500 µM 322 
substrate concentrations (Figure 5). Diazinon was metabolized to four putative metabolites, 323 
two of which were identified as diazoxon and hydroxydiazinon. (Figure 6). The other two 324 
putative metabolites could not be further characterized due to limiting quantities. 325 
 326 
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4.  Discussion 327 
 328 
4.1.  CYP6G3 expression and solubility 329 
  330 
The bicistronic expression vector, pCW6g3-Barnes/fCPR, was constructed with L. 331 
cuprina Cyp6g3 and housefly fCPR. The expression yield of CYP6G3 was adequate with the 332 
standard expression protocol employed without further optimization. This contrasts markedly 333 
with the behaviour of the D. melanogaster CYP6G1, which required specific expression 334 
conditions to prevent a loss of holoprotein with a concurrent increase in P420 (Cheesman et 335 
al., 2013). Although a minor P420 component was also seen in the CYP6G3 spectra, the 336 
facile expression of CYP6G3 may indicate an increased stability of this form compared to 337 
CYP6G1. 338 
 339 
4.2. Characterization of the activity of the recombinant enzyme towards marker substrates 340 
 341 
To identify marker substrates for characterizing CYP6G3, thirteen potential substrates 342 
were screened. CYP6G3 exhibited pNAOD and 7ECOD activity. No significant activity was 343 
observed toward p-nitrophenol hydroxylation, coumarin-7-hydroxylation, 7-344 
benzyloxyresorufin O-dealkylation, or the dealkylation of several P450-glo substrates 345 
(luciferin-ME, -CEE, -H, -BE, -PFBE, -ME-EGE, or -H-EGE).  346 
Many P450 enzymes exhibit increased catalytic rates in the presence of cytochrome b5 347 
(Yamazaki et al., 2002). To determine the effect of fb5 on CYP6G3 activity, pNAOD was 348 
used as a probe substrate. The kcat of CYP6G3-mediated pNAOD was increased roughly two 349 
fold in the presence of fb5, while the KM was not significantly changed (Fig 2), suggesting an 350 
effect on overall turnover but not interactions with substrate. Notably, neither the kcat nor the 351 
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KM of CYP6G1-mediated pNAOD was affected by the addition of fb5 (Cheesman et al., 352 
2013). Other insect P450s, including CYP6A1 from M. domestica (Guzov et al., 1996; 353 
Murataliev et al., 2008), CYP6CM1vQ from Bemisia tabaci (Karunker et al., 2009) and 354 
CYP6M2 from Anopheles gambiae (Stevenson et al., 2011), have shown increased rates of 355 
catalysis in the presence of fb5. 356 
 357 
4.3. Screening for pesticide interactions with CYP6G3   358 
 359 
Oxidative metabolism has been implicated in the resistance of L. cuprina to 360 
organochlorine, organophosphorus, benzoylurea, pyrethroid, and carbamate pesticides 361 
(Hughes, 1982; Hughes and Devonshire, 1982; Kotze, 1993; Kotze, 1995; Kotze and Sales, 362 
1994). Identification and characterization of the specific enzymes involved in L. cuprina 363 
oxidative metabolism may be useful to predict and respond to future instances of insecticide 364 
resistance in L. cuprina. In particular, CYP6G3, shares 60% and 72% sequence identity with 365 
CYP6G1 from D. melanogaster and CYP6G4 from M. domestica, respectively. These P450s 366 
have both been implicated in the resistance to multiple pesticides (Feyereisen, 2012; Gao et 367 
al., 2012; Hojland et al., 2014).  The high degree of sequence identity and the data presented 368 
here indicate that the Cyp6G3 gene could confer resistance to multiple insecticides if it were 369 
expressed at suitably high levels.  The P450 genes of L. cuprina have not been fully annotated 370 
as yet (Anstead et al., 2015), so it is not clear whether other P450s in this species might also 371 
have this potential.  For CYP6G3, two complementary approaches were used to investigate 372 
pesticide interaction with the active site, namely inhibition of a marker activity and ligand-373 
induced binding spectra.  374 
 375 
  376 
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Since 7ECOD activity was the more sensitive of the two marker substrates metabolized 377 
by CYP6G3, this assay was used to screen for inhibition of CYP6G3 activity in high 378 
throughput fashion. Activity was supported by CuOOH to avoid interference by NADPH in 379 
the high throughput fluorescence assay and allow continuous monitoring of rates. The 380 
organochlorine insecticides, DDT and endosulfan, both inhibited CYP6G3-mediated 7ECOD 381 
activity and induced type I spectral binding spectra. DDT was used to control flystrike in 382 
Australia from 1948 to 1954, after which dieldrin, a related organochlorine compound and 383 
more effective insecticide, was preferred (Levot, 1995a). L. cuprina resistance to dieldrin 384 
appeared in 1958 (Levot, 1995a). However, the principal, observed genotype of resistance, 385 
Rdl, is associated with mutation of a pesticide target, not with oxidative metabolism. Resistant 386 
flies have a mutated neuronal GABA receptor, which reduces dieldrin toxicity (McKenzie and 387 
Batterham, 1998; Smyth et al., 1992). Nonetheless, the epoxidation of aldrin, another 388 
organochlorine insecticide, is a well-characterized reaction catalyzed by L. cuprina 389 
microsomes (Kotze, 1993; Kotze, 1995). Furthermore, CYP6G1 has been associated with D. 390 
melanogaster resistance to DDT (Daborn et al., 2002) and has been shown to bind both DDT 391 
and endosulfan (Cheesman et al., 2013). The current data demonstrate an interaction of DDT 392 
and endosulfan with the active site of CYP6G3 and suggest that CYP6G3 could be an 393 
additional mechanism of L. cuprina resistance to organochlorine insecticides.    394 
The organophosphorus insecticides malathion and chlorfenvinphos also inhibited 395 
CYP6G3-mediated 7ECOD activity and induced type I binding spectra. Organophosphorus 396 
insecticides were used heavily in Australia after resistance developed to organochlorine 397 
insecticides. In 1965, about nine years after introduction, resistance to organophosphorus 398 
insecticides was observed in Australian populations of L. cuprina (Levot, 1995a). The 399 
primary mode of resistance, which has been observed in field samples and in laboratory-400 
evolved resistant lines, involves carboxylesterase-mediated degradation (Claudianos et al., 401 
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1999; McKenzie and Batterham, 1998). However, several reports have implicated P450 402 
enzymes in the ability of L. cuprina to degrade organophosphorus compounds (Hughes and 403 
Devonshire, 1982; Kotze, 1995). The inhibition of CYP6G3 activity by chlorfenvinphos and 404 
malathion and their tight binding in a type I format are both consistent with these molecules 405 
being CYP6G3 substrates. Thus, CYP6G3 is a potential candidate for oxidative degradation 406 
of organophosphorus insecticides in L. cuprina.  407 
Little significant inhibition was observed with lufenuron, carbaryl, dicyclanil, lauric 408 
acid, and biphenyl. Similarly to the current work with CYP6G3, at concentrations up to 100 409 
µM, biphenyl induced little inhibition with CYP6G1 (Cheesman et al., 2013). Lauric acid is a 410 
substrate of D. melanogaster CYP6A8 (Helvig et al., 2004), but does not seem to interact 411 
with either the active site of CYP6G3 or CYP6G1 at concentrations up to 100 µM. 412 
Lufenuron, a benzoylurea compound, and carbaryl, a carbamate, did not significantly inhibit 413 
CYP6G3; however, a slight trend of increasing inhibition is apparent at higher carbaryl and 414 
lufenuron concentrations. Finally, dicyclanil, a triazine insecticide, did not inhibit CYP6G3 at 415 
concentrations up to 100 uM. Dicyclanil and cyromazine are both currently used to control 416 
blowfly in Australia, and the first documented case of cyromazine resistance was recorded 417 
recently (Levot, 2012).  418 
Although imidacloprid is a substrate of CYP6G1 (Fusetto et al., 2017; Hoi et al., 2014; 419 
Jouβen et al., 2010), in this work, only weak inhibition of CYP6G3 was seen at millimolar 420 
concentrations. Likewise, imidacloprid elicited only a very weak type I binding spectrum. 421 
However metabolic experiments confirmed that CYP6G3 metabolized imidacloprid to the 5-422 
hydroxy and olefin metabolites, both of which are toxic in other insects (Fusetto et al., 2017; 423 
Nauen et al., 2001). Activity at 500 µM was markedly higher than at 25 µM suggesting 424 
CYP6G3 has a low affinity for imidacloprid, consistent with the failure to see significant 425 
inhibition of 7ECOD activity.  426 
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Diazinon showed a weak Type I binding spectrum with CYP6G3 with a Kd value of 427 
23 +/- 3 µM but only inhibited 7ECOD activity at millimolar concentrations, suggesting that 428 
it may bind only very weakly to the active site. However CYP6G3 metabolized diazinon to 429 
four putative metabolites, two of which were identified as diazoxon and hydroxydiazinon. 430 
The apparent metabolites at ~ 6 and 26 min could not be conclusively identified, but it is 431 
possible that one may be IMP. The limited inhibition of CYP6G3 by diazinon, its micromolar 432 
Kd value and relatively weak type I spectrum is consistent with diazinon binding at the active 433 
site in multiple conformations, leading to multiple metabolites. 434 
A role has been proposed for P450s in diazinon metabolism of the phosphorothioate to 435 
the toxic oxon metabolite, diazoxon, which is metabolized further by an esterase in resistant 436 
L. cuprina populations (Hartley et al., 2006; Newcomb et al., 1997). While CYP6A, CYP6B 437 
and CYP12A enzymes have been shown to metabolize diazinon in other species (reviewed in 438 
(Feyereisen, 2012)), the diazinon desulfurylase in L. cuprina has not previously been 439 
reported. The general P450 inhibitor, piperonyl butoxide, exerted a biphasic effect on 440 
diazinon toxicity dependent on the concentration, which may be related to the balance 441 
between diazinon bioactivation to the oxon and clearance to the hydroxylated diazinon 442 
metabolites (Li et al., 2007a; Mutch and Williams, 2006; Wilson et al., 1999). The data 443 
presented here suggest that CYP6G3 is involved in both activation of diazinon to diazoxon 444 
and its detoxification to hydroxydiazinon metabolites consistent with this biphasic behaviour. 445 
 446 
4.4. Concluding comments 447 
 448 
The in vitro characterization of P450 enzymes can provide valuable information about the 449 
degradative capabilities of industrially-relevant pests and offer clues to the design of more 450 
effective insecticides. The heterologous expression of CYP6G3, a P450 enzyme from the 451 
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economically important pest L. cuprina, enabled the characterization CYP6G3 activity 452 
towards pesticides commonly used for flystrike, and revealed that CYP6G3 can metabolize 453 
imidacloprid and diazinon. The inhibition of marker activity and type I ligand binding spectra 454 
shown by the organochlorine insecticides, DDT and endosulfan, and by the 455 
organophosphorous insecticides, chlorfenvinphos and malathion, are strong indicators that 456 
CYP6G3 is also capable of degrading these molecules. However, a conclusive demonstration 457 
that these molecules are indeed substrates of CYP6G3 will require additional work to identify 458 
reaction products. This work is a step toward a complete characterization of the catalytic 459 
capabilities of CYP6G3 and other xenobiotic-metabolizing P450 enzymes from L. cuprina.  460 
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  469 
Figure legends 470 
 471 
Figure 1. CO-difference spectrum of microsomes containing CYP6G3. 472 
 473 
Figure 2. A) Initial rate of 7-ethoxycoumarin O-dealkylation (7ECOD) by CYP6G3 supported 474 
by cumene hydroperoxide. B) Initial rate of p-nitroanisole O-dealkylation (pNAOD) by 475 
CYP6G3 supported by fCPR (●) with and (○) without fb5. 476 
 477 
Figure 3. Inhibition of CYP6G3-mediated 7ECOD (1 mM 7EC) by varying concentrations of 478 
A) chlorfenvinphos, B) malathion, C) endosulfan, D), DDT, and E) ketoconazole. 479 
 480 
Figure 4. Ligand-induced difference spectra and best fit to the concentration dependence of 481 
the difference magnitude for CYP6G3 binding.  A) and B) chlorfenvinphos, C) and D) 482 
malathion, E) and F) ketoconazole, G) and H) DDT, I) and J) endosulfan, and K) and L) 483 
diazinon. 484 
 485 
Figure 5. Imidacloprid metabolism by CYP6G3. Bacterial membranes containing 486 
recombinant CYP6G3 (0.10 µM P450) and fCPR (0.18 µM) were incubated with either 25 487 
µM or 500 µM imidacloprid for two hours under conditions supporting P450 catalysis. 488 
Controls lacked P450 (CPR only) or an NADPH-generating system (-NGS), were quenched at 489 
time zero, or contained only substrate and buffer (substrate only). Data represent the means 490 
+/- S.D. of three independent experiments. Metabolite formation was significantly higher in 491 
complete reactions compared to the highest control (CPR only) at the p < 0.05 level for assays 492 
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done with 25 µM substrate concentration for both metabolites and at the p < 0.01 (5-493 
hydroxyimidacloprid) and p < 0.001 (imidacloprid olefin) levels for 500 µM imidacloprid. 494 
 495 
Figure 6. HPLC Chromatogram from extracts of reactions exploring diazinon metabolism by 496 
CYP6G3. Bacterial membranes containing recombinant CYP6G3 (0.50 µM P450) and fCPR 497 
(0.75 µM) were incubated with 100 µM diazinon for two hours under conditions supporting 498 
P450 catalysis (upper, blue trace). Controls lacked P450 (fCPR only; lower, pink trace) or an 499 
NADPH-generating system (-NGS, middle, black trace). 500 
 501 
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Tables 
 
Table 1 
Steady-state kinetic constants of 6G3 7ECOD activity supported by CuOOH and of 
6G3 pNAOD activity supported by fCPR in the presence and absence of fb5 
System Activity kcata KMb 
6G3 CuOOH  7ECOD 1.7 ± 0.1  1042 ± 96 
6G3 fCPR NADPH pNAOD 9.6 ± 0.2  9.8 ± 1.1 
6G3 fCPR fb5 
NADPH 
pNAOD 17.8 ± 0.5  13.4 ± 1.9 
a
 nmol / min / nmol P450 
b
 µM 
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Table 2 
IC50 values for the inhibition of CYP6G3 7ECOD activity and spectral binding 
parameters for ligand binding to CYP6G3 
Ligand IC50a KS b Hill 
Coefficient 
∆Amax ∆Amax / 
KS 
endosulfan 0.23 1.4 +/- 0.1 n.a.c 0.064 +/- 
0.001 
0.046 
ketoconazole 5.5 4.3 +/- 0.3 1.6 +/- 0.1 0.019 +/- 
0.001 
0.0044 
chlorfenvinphos 26.8 1.0 +/- 0.1 n.a. 0.056 +/- 
0.001 
0.056 
malathion >100 5.4 +/- 0.4 n.a. 0.030 +/- 
0.001 
0.0056 
DDT >100 28 +/- 1 n.a. 0.046 +/- 
0.001 
0.0016 
lufenuron >100 n.d.d n.a. n.d. n.d. 
carbaryl >100 n.d. n.a. n.d. n.d. 
dicyclanil >100 n.d. n.a. n.d. n.d. 
imidacloprid >100 n.d. n.a. n.d. n.d. 
biphenyl >100 n.d. n.a. n.d. n.d. 
diazinon >100 23 +/- 3 n.a. 0.0167 
+/- 
0.0006 
0.0007 
a
 µM, IC50 values were determined using 1 mM 7ECOD supported by 500 µM 
CuOOH 
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b
 µM 
c
 not applicable; data were best fit using a simple rectangular hyperbolic binding 
curve 
d
 not determined 
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The cytochrome P450, CYP6G3, has been characterised from the Australian Sheep 
Blowfly, an important agricultural pest.  
 
Recombinant CYP6G3 is catalytically active towards marker substrates and 
stimulated by cytochrome b5. 
 
CYP6G3 binds and is inhibited by the insecticides DDT, endosulfan, malathion and 
chlorfenvinphos.  
 
CYP6G3 metabolizes imidacloprid to the 5-hydroxy- and olefin metabolites and 
diazinon to diazoxon and hydroxydiazinon. 
 
